Upload
votruc
View
214
Download
0
Embed Size (px)
Citation preview
THE FIRST ACTIVE HEMOSTATIC POWDER3 INGREDIENTS FOR
A SYNERGISTIC AND SIMULTANEOUS EFFECT1
A UNIQUE AND INNOVATIVE FORMULATION2,3
1. biom’up, internal data. 2. HEMOBLAST™ Bellows IFU. 3. Patented formulation.
CHONDROITIN SULFATE
CLOT STABILIZATION
COLLAGEN POWDER
PLATELET AGGREGATIONCLOTTING CASCADE
INITIATION
POOLED THROMBIN
CLOT FORMATIONCONVERSION OF
FIBRINOGEN INTO FIBRIN FORMATION OF A FIBRIN
NETWORKAPPLICATION
COHESIVE AND STABLE CLOT
Red blood cell
HEMOBLAST™ Bellows
Triple collagen helix
Chondroitin sulfate
Inactivated platelet
Activated platelet
Fibrin
Red blood cell
HEMOBLAST™ Bellows
Triple collagen helix
Chondroitin sulfate
Platelet
Activated platelet
Fibrin
0 10 20 30 40 50 60 70
DEVELOPED BY AND FOR SURGEONS
EFFICIENT1
COHESIVE & STABLE CLOT MAINTAINED VISIBILITY AFTER APPLICATION
READY AND EASY TO USE1
NO PREPARATION TIME NEEDEDERGONOMIC AND INTUITIVE APPLICATOR
COST EFFECTIVE2
ON-DEMAND USAGE CROSS-OVER PRODUCT SAVES TRAINING TIME
THE ACTIVE HEMOSTAT WITH THE LARGEST COVERAGE AREA3
1. biom’up, internal data. Data derived from preclinical animal studies. Results may differ in clinical use. 2. biom’up, company data. Data derived from clinical use of 125 cases in Germany and France (PME report). 3. biom’up, company data. HEMOBLAST™ Bellows or one of its competitors was uniformly applied on the slice until the operator deemed the device as emptied. Macroscopic picture(s) were taken for each assay with a camera mounted on a support (similar position and distance from the liver slice and same magnification between assays). Three devices were used for each product.
MEAN (+/- SD) AREA COVERED3
cm2
Flowabe Gelatin +Thrombin (5 mL)
Collagen patch+ Thrombin + Fibrinogen
(9.5 cm*4.8 cm)
HEMOBLAST™ BellowsThe first active hemostatic
powder (1.65 g)
-19%52.69 cm2 (± 2.22)
64.96 cm2 (± 5.75)
30.38 cm2 (± 3.3) -53%
EXPERIENCED IN THE CLINICAL SETTING
SPINE SURGERYExample of indications:LaminectomyCorporectomyDiscectomy
Professor POINTILLART CHU Bordeaux (Bordeaux, France)Discectomy and cervical arthrodesis (anterior approach)
HEPATIC SURGERYExample of indications:
HepatectomyTumorectomy
Liver transplant
Professor LAURENTCHU Bordeaux
(Bordeaux, France)Hepatectomy (cirrhotic)
HERNIA SURGERYExample of indications:
Incisional herniaStomial hernia
Doctor DABROWSKIClinique Saint Omer (Lille, France)
Incisional hernia
CARDIOVASCULAR SURGERYExample of indications: Coronary artery bypassHeart transplantReoperative proceduresValve replacements and repairs
Doctor EL BATTIHEGP (Paris, France)Abdominal Aorta
www.hemoblast.com
OF SURGEONS STATED HEMOBLAST™ BELLOWS COULD REPLACE ANOTHER HEMOSTATIC AGENT.1
OF SURGEONS WHO TRIED HEMOBLAST™ BELLOWS WERE SATISFIED WITH HOW IT PERFORMED AND WOULD RECOMMEND
THAT THEIR HOSPITAL BUY IT.*1
* Including 58% «Very satisfied» and 36% «Satisfied». 1. biomup, internal data. Data derived from clinical use of 125 cases in Germany and France (PME report).Legal Information : HEMOBLAST™ Bellows - Implantable Medical device Class III for surgery reserved for use by qualified healthcare professionals, reimbursement depends on each country - NOT FOR SALE IN THE USA. Read the instructions for use on the packaging carefully before use. CE0086: BSI - Manufacturer : biom’up SA France.
88%
93%
QUANTITY PER BELLOWS (G) PER PACK REFERENCE
1.65 1 BELLOWS AND A SHORT 10CM CANNULA BQF02
GOOD VISIBILITY AFTER APPLICATION
EASY AND READY TO USE
THE CLOT IS STABLE
SIMPLE APPLICATION
GOOD BLEEDING SITE
ACCESSIBILITY